Comparative exploration of tumor and adjacent normal lung tissue has also been leveraged to determine the antigenic landscape of so-called “cold” lung cancers, with investigators finding a relatively greater frequency of neoantigens located within HLA-I presentation hotspots in CD3 + CD8 + T-cell-excluded tumors (Kraemer et al. 2023). Here, CD8A is linked to neoplasm.